ICE

SEC source: 0001209191-22-047490 · doc4.xml · nonDerivative · entry 1

Foley Douglas · CIK 0001918894 · SVP, HR & Administration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,402

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 18,572 shares of common stock and 3,830 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-032604 · doc4.xml · derivative · entry 10

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,206

Underlying: Common Stock · 1,751 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-22-032604 · doc4.xml · derivative · entry 9

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,680

Underlying: Common Stock · 63,680 shares

Expires 2024-01-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-22-032604 · doc4.xml · nonDerivative · entry 5

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,277,280

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F4 · price: The price range for the aggregate amount sold by the direct holder is $99.29 - $100.13. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,217,436 shares of common stock and 59,844 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-032604 · doc4.xml · nonDerivative · entry 4

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,313,366

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $98.29 - $99.28. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-032604 · doc4.xml · nonDerivative · entry 3

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,342,889

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $97.29 - $98.28. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-032604 · doc4.xml · nonDerivative · entry 2

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,360,901

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-22-032604 · doc4.xml · nonDerivative · entry 1

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,359,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-22-032604 · doc4.xml · nonDerivative · entry 7

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · CPEX

Disclosed balance after: 3,011,705

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F7 · price: The price range for the aggregate amount sold by the direct holder is $97.74 - $98.49. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F8 · balance_after: As previously reported, the reporting person also indirectly owns 3,011,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

SEC source: 0001209191-22-032604 · doc4.xml · nonDerivative · entry 6

Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · CPEX

Disclosed balance after: 3,015,729

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F6 · price: The price range for the aggregate amount sold by the direct holder is $96.74 - $97.73. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-031887 · doc4.xml · nonDerivative · entry 1

Hague William Jefferson · CIK 0001652762 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,127

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 13,889 shares of common stock and 2,238 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2023.

SEC source: 0001209191-22-031883 · doc4.xml · nonDerivative · entry 1

Foley Douglas · CIK 0001918894 · SVP, HR & Administration

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,002

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 20,172 shares of common stock and 3,830 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-031327 · doc4.xml · nonDerivative · entry 1

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,119

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 3,792 shares of common stock and 3,944 unvested restricted stock units ("RSUs"), and 6,383 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-030090 · doc4.xml · nonDerivative · entry 1

Hague William Jefferson · CIK 0001652762 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,710

F1 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 14,472 shares of common stock and 2,238 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2023.

SEC source: 0001209191-22-030093 · doc4.xml · nonDerivative · entry 1

Silver Caroline Louise · CIK 0001821735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,017

F1 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 3,779 shares of common stock and 2,238 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2023.

SEC source: 0001209191-22-030126 · doc4.xml · nonDerivative · entry 1

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,611

F1 · shares: Represents shares of restricted stock issued to the filing person on May 15, 2020. The restricted stock units vest over three years (1/3 on May 15, 2021, 1/3 on May 15, 2022 and 1/3 on May 15, 2023). Of the 2,674 shares, 891 shares were issued on May 16, 2022, of which 399 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 892 shares are scheduled to be issued on May 15, 2023 and taxes for this issuance will be withheld and reported at the time of vesting.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 4,284 shares of common stock and 3,944 unvested restricted stock units ("RSUs"), and 6,383 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-029690 · doc4.xml · nonDerivative · entry 1

NOONAN THOMAS E · CIK 0001079742 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,471

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 14,487 shares of common stock and 1,984 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2022.

SEC source: 0001209191-22-029677 · doc4.xml · nonDerivative · entry 1

Farooqui Duriya M · CIK 0001699994 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,377

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 9,393 shares of common stock and 1,984 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2022.

SEC source: 0001209191-22-029682 · doc4.xml · nonDerivative · entry 1

Hague William Jefferson · CIK 0001652762 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,833

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,238 restricted stock units awarded, 1,984 were awarded as compensation for service on the Issuer's board and 254 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Futures Europe.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 14,595 shares of common stock and 2,238 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2022.

SEC source: 0001209191-22-029698 · doc4.xml · nonDerivative · entry 1

SPRIESER JUDITH A · CIK 0001206994 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,564

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,238 restricted stock units awarded, 1,984 were awarded as compensation for service on the Issuer's board and 254 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Credit LLC.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 29,326 shares of common stock and 2,238 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2022.

SEC source: 0001209191-22-029686 · doc4.xml · nonDerivative · entry 1

Mulhern Mark F · CIK 0001342425 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,398

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 3,414 shares of common stock and 1,984 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2022.

SEC source: 0001209191-22-029693 · doc4.xml · nonDerivative · entry 1

Silver Caroline Louise · CIK 0001821735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,142

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share. Of the 2,238 restricted stock units awarded, 1,984 were awarded as compensation for service on the Issuer's board and 254 were awarded as compensation for service on the board of Issuer's subsidiary, ICE Clear Europe Limited.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 3,904 shares of common stock and 2,238 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2022.

SEC source: 0001209191-22-029702 · doc4.xml · nonDerivative · entry 1

Tirinnanzi Martha A · CIK 0001916305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,984

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

SEC source: 0001209191-22-029673 · doc4.xml · nonDerivative · entry 1

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,010

F1 · shares: Represents shares of restricted stock issued to the filing person on May 13, 2022. This award of restricted stock vests over three years (1/3 on each anniversary of the award date).

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 3,792 shares of common stock and 4,835 unvested restricted stock units ("RSUs"), and 6,383 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-029669 · doc4.xml · nonDerivative · entry 1

Cooper Shantella E. · CIK 0001698291 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,398

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 3,414 shares of common stock and 1,984 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2022.

SEC source: 0001209191-22-029663 · doc4.xml · nonDerivative · entry 1

Bowen Sharon · CIK 0001724974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,873

F1 · shares: Represents restricted stock units. This award of restricted stock units vests on the one-year anniversary of the award date and may be settled only by delivery of shares of the Issuer's common stock, par value $0.01 per share.

F2 · balance_after: The common stock number referred in Table 1 is an aggregate number and represents 10,889 shares of common stock and 1,984 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 13, 2022.

SEC source: 0001209191-22-024155 · doc4.xml · derivative · entry 3

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,028

Underlying: Common Stock · 11,000 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-22-024155 · doc4.xml · nonDerivative · entry 2

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,229

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $127.42 - $129.65. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 18,058 shares of common stock and 9,171 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-024155 · doc4.xml · nonDerivative · entry 1

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,229

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-22-023492 · doc4.xml · derivative · entry 4

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,631

Underlying: Common Stock · 1,313 shares

Expires 2029-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-22-023492 · doc4.xml · nonDerivative · entry 2

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,958

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The common stock number referred in Table I is an aggregate number and represents 3,792 shares of common stock, 1,783 unvested restricted stock units ("RSUs"), and 6,383 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-023492 · doc4.xml · derivative · entry 3

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,383

Underlying: Common Stock · 1,492 shares

Expires 2028-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-22-023492 · doc4.xml · nonDerivative · entry 1

Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,645

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-22-018170 · doc4.xml · derivative · entry 5

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,028

Underlying: Common Stock · 5,037 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-22-018170 · doc4.xml · derivative · entry 4

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,995

Underlying: Common Stock · 5,963 shares

Expires 2026-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-22-018170 · doc4.xml · nonDerivative · entry 3

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,229

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 18,058 shares of common stock and 9,171 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-018170 · doc4.xml · nonDerivative · entry 2

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,229

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-22-018170 · doc4.xml · nonDerivative · entry 1

Wassersug Mark · CIK 0001722544 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-22-017099 · doc4.xml · derivative · entry 3

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36,570 shares

Expires 2025-01-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested.

SEC source: 0001209191-22-017099 · doc4.xml · nonDerivative · entry 2

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,580

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $135.00 - $135.15. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 172,272 shares of common stock and 15,308 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-017099 · doc4.xml · nonDerivative · entry 1

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

SEC source: 0001209191-22-014775 · doc4.xml · nonDerivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,753

F1 · shares: Represents shares of restricted stock issued to the filing person on February 26, 2021. The restricted stock units vest over three years (1/3 on February 26, 2022, 1/3 on February 26, 2023 and 1/3 on February 26, 2024). Of the 2,719 shares, 906 shares were issued on February 28, 2022, of which 411 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 1,813 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 7,214 shares of common stock and 2,449 unvested restricted stock units ("RSUs"), and 6,090 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting.

SEC source: 0001209191-22-013197 · doc4.xml · nonDerivative · entry 1

Gardiner Warren · CIK 0001855007 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,164

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 6,719 shares of common stock and 3,355 unvested restricted stock units ("RSUs"), and 6,090 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and will be reported at the time of vesting.

SEC source: 0001209191-22-013201 · doc4.xml · nonDerivative · entry 6

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,580

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F7 · price: The price range for the aggregate amount sold by the direct holder is $127.30 - $128.03. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F8 · balance_after: The common stock number referred in Table I is an aggregate number and represents 172,272 shares of common stock and 15,308 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

SEC source: 0001209191-22-013201 · doc4.xml · nonDerivative · entry 5

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,812

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F6 · price: The price range for the aggregate amount sold by the direct holder is $125.96 - $126.92. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-013201 · doc4.xml · nonDerivative · entry 4

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,313

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F5 · price: The price range for the aggregate amount sold by the direct holder is $124.92 - $125.90. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-013201 · doc4.xml · nonDerivative · entry 3

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,373

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F4 · price: The price range for the aggregate amount sold by the direct holder is $123.81 - $124.80. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-013201 · doc4.xml · nonDerivative · entry 2

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,042

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F3 · price: The price range for the aggregate amount sold by the direct holder is $122.27 - $123.23. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-013201 · doc4.xml · nonDerivative · entry 1

Goone David S · CIK 0001343869 · Chief Strategic Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,530

F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F2 · price: The price range for the aggregate amount sold by the direct holder is $121.22 - $121.39. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-013207 · doc4.xml · nonDerivative · entry 6

Surdykowski Andrew J · CIK 0001755922 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,375

F2 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

F7 · price: The price range for the aggregate amount sold by the direct holder is $127.31 - $128.05. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

F8 · balance_after: The common stock number referred in Table I is an aggregate number and represents 35,992 shares of common stock and 6,383 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.